Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Stocks Surging Today?

Page 1 of 2

It’s Thursday and shareholders of BofI Holding, Inc. (NASDAQ:BOFI), and Five Prime Therapeutics Inc (NASDAQ:FPRX) are certainly happy as the value of their stakes in those stocks has soared by 17% and 52.79% respectively in early morning trading. Sentiment is improving around Bank of the Internet, while Five Prime Therapeutics recently announced a big deal with Bristol-Myers Squibb Co (NYSE:BMY). Given the relative strength of the three equities, let’s take a closer look, and if applicable, analyze any relevant hedge fund sentiment toward the three stocks.

Wall Street Bull

Wall Street Bull

Why do we pay attention to hedge fund sentiment? Most investors ignore hedge funds’ moves because as a group their average net returns trailed the market since 2008 by a large margin. Unfortunately, most investors don’t realize that hedge funds are hedged and they also charge an arm and a leg, so they are likely to underperform the market in a bull market. We ignore their short positions and by imitating hedge funds’ stock picks independently, we don’t have to pay them a dime. Our research has shown that hedge funds’ long stock picks generate strong risk adjusted returns. For instance the 15 most popular small-cap stocks outperformed the S&P 500 Index by an average of 95 basis points per month in our back-tests spanning the 1999-2012 period. We have been tracking the performance of these stocks in real-time since the end of August 2012. After all, things change and we need to verify that back-test results aren’t just a statistical fluke. We weren’t proven wrong. These 15 stocks managed to return more than 102% over the last 37 months and outperformed the S&P 500 ETF (SPY) by 53 percentage points (see more details here).

BofI Holding, Inc. (NASDAQ:BOFI) is up after management hosted a conference call on Wednesday evening in response to a New York Times article reporting that a former auditor of the bank said the company was cutting corners and was perhaps engaged in wrongdoing. The former auditor hinted that the bank’s borrowers “may have included foreign nationals who might be off-limits under federal anti-money-laundering laws.” Many investors sold first and asked questions later on Wednesday and Bank of the Internet’s stock fell by around 30%. It seems last night’s investor conference answered some questions and soothed some concerns. In addition, several analysts defended the bank, including analysts at FBR Capital, who reiterated their ‘Outperform’ rating and $132 price target. The analysts at FBR Capital think the recent pullback is a significant buying opportunity, although the uncertainty clearly isn’t over yet.

Follow Bofi Holding Inc. (NASDAQ:BOFI)
Trade (NASDAQ:BOFI) Now!

Five Prime Therapeutics Inc (NASDAQ:FPRX) is up after announcing a favorable deal with Bristol-Myers Squibb Co (NYSE:BMY) concerning the development of the company’s colony stimulating factor 1 receptor antibody program (FPA008) in combination with nivolumab and other therapies. Five Prime is entitled to receive up to $1.74 billion for FPA008, with a $350 million upfront payment and over $1 billion in development and milestone payments. The company is also entitled to double-digit royalties on future sales and has the option to co-promote in the United States.

On the next page, we’ll analyze hedge fund sentiment towards Five Prime and Bristol-Myers Squibb.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!